https://www.gmpguideline.com/data-integrity-inspections-in-pharmaceutical-quality-systems-3/2026-04-30T16:09:00+00:00https://www.gmpguideline.com/role-of-data-integrity-reviews-in-gmp-inspection-programs-3/2026-04-30T17:26:00+00:00https://www.gmpguideline.com/how-data-integrity-inspection-focus-is-structured-in-pharma-2/2026-04-30T18:43:00+00:00https://www.gmpguideline.com/regulatory-basis-for-data-integrity-inspections-in-gmp-environments/2026-04-30T20:00:00+00:00https://www.gmpguideline.com/key-elements-of-data-integrity-inspection-readiness/2026-04-30T21:17:00+00:00https://www.gmpguideline.com/application-of-alcoa-principles-during-inspection-preparation/2026-04-30T22:34:00+00:00https://www.gmpguideline.com/regulatory-basis-for-data-integrity-inspections-in-gmp-environments-2/2026-04-30T20:00:00+00:00https://www.gmpguideline.com/key-elements-of-data-integrity-inspection-readiness-2/2026-04-30T21:17:00+00:00https://www.gmpguideline.com/regulatory-expectations-for-data-integrity-controls-during-inspections/2026-04-30T23:51:00+00:00https://www.gmpguideline.com/failure-to-review-audit-trails-in-gmp-critical-systems/2026-05-01T01:08:00+00:00https://www.gmpguideline.com/backdated-entries-and-undocumented-changes-during-data-integrity-reviews/2026-05-01T02:25:00+00:00https://www.gmpguideline.com/use-of-shared-logins-and-weak-access-controls-in-regulated-systems/2026-05-01T03:42:00+00:00https://www.gmpguideline.com/inspection-focus-on-raw-data-completeness-and-contemporaneous-recording/2026-05-01T04:59:00+00:00https://www.gmpguideline.com/metadata-gaps-affecting-reliability-of-electronic-gmp-records/2026-05-01T06:16:00+00:00https://www.gmpguideline.com/use-of-shared-logins-and-weak-access-controls-in-regulated-systems-2/2026-05-01T03:42:00+00:00https://www.gmpguideline.com/inspection-focus-on-raw-data-completeness-and-contemporaneous-recording-2/2026-05-01T04:59:00+00:00https://www.gmpguideline.com/absence-of-qa-oversight-during-critical-manufacturing-steps/2026-05-04T17:41:00+00:00https://www.gmpguideline.com/regulatory-expectations-for-glp-and-gmp-laboratory-compliance/2026-05-04T17:41:00+00:00https://www.gmpguideline.com/audit-findings-related-to-weak-risk-based-validation-strategy/2026-05-04T17:41:00+00:00https://www.gmpguideline.com/data-governance-weaknesses-identified-during-data-integrity-inspections/2026-05-01T07:33:00+00:00https://www.gmpguideline.com/regulatory-expectations-for-qa-presence-in-production/2026-05-04T18:58:00+00:00https://www.gmpguideline.com/uncontrolled-worksheets-and-unofficial-records-in-gmp-operations/2026-05-01T08:50:00+00:00https://www.gmpguideline.com/regulatory-risks-from-inadequate-backup-and-restore-controls/2026-05-01T10:07:00+00:00https://www.gmpguideline.com/data-governance-weaknesses-identified-during-data-integrity-inspections-2/2026-05-01T07:33:00+00:00https://www.gmpguideline.com/uncontrolled-worksheets-and-unofficial-records-in-gmp-operations-2/2026-05-01T08:50:00+00:00https://www.gmpguideline.com/regulatory-risks-from-inadequate-backup-and-restore-controls-2/2026-05-01T10:07:00+00:00https://www.gmpguideline.com/failure-to-reconcile-paper-and-electronic-records-during-inspection-review/2026-05-01T11:24:00+00:00https://www.gmpguideline.com/training-deficiencies-related-to-alcoa-and-data-governance-principles/2026-05-01T12:41:00+00:00https://www.gmpguideline.com/management-oversight-gaps-in-data-integrity-compliance-programs/2026-05-01T13:58:00+00:00https://www.gmpguideline.com/recurring-data-integrity-observations-due-to-weak-remediation-controls/2026-05-01T15:15:00+00:00https://www.gmpguideline.com/supplier-and-third-party-data-integrity-risks-during-inspections/2026-05-01T16:32:00+00:00https://www.gmpguideline.com/recurring-data-integrity-observations-due-to-weak-remediation-controls-2/2026-05-01T15:15:00+00:00https://www.gmpguideline.com/effectiveness-verification-gaps-after-prior-data-integrity-findings/2026-05-01T17:49:00+00:00https://www.gmpguideline.com/supplier-and-third-party-data-integrity-risks-during-inspections-2/2026-05-01T16:32:00+00:00https://www.gmpguideline.com/effectiveness-verification-gaps-after-prior-data-integrity-findings-2/2026-05-01T17:49:00+00:00https://www.gmpguideline.com/remote-and-virtual-audits-in-pharmaceutical-compliance-programs/2026-05-01T19:06:00+00:00https://www.gmpguideline.com/role-of-remote-auditing-in-modern-gmp-oversight/2026-05-01T20:23:00+00:00https://www.gmpguideline.com/how-virtual-audit-processes-are-structured-in-pharma-organizations/2026-05-01T21:40:00+00:00https://www.gmpguideline.com/regulatory-relevance-of-remote-audit-practices-in-gmp-systems/2026-05-01T22:57:00+00:00https://www.gmpguideline.com/key-elements-of-effective-remote-and-virtual-audits/2026-05-02T00:14:00+00:00https://www.gmpguideline.com/application-of-virtual-audit-techniques-in-supplier-and-site-oversight/2026-05-02T01:31:00+00:00https://www.gmpguideline.com/regulatory-expectations-for-remote-audit-planning-and-execution/2026-05-02T02:48:00+00:00https://www.gmpguideline.com/failure-to-verify-documentary-evidence-during-remote-audits/2026-05-02T04:05:00+00:00https://www.gmpguideline.com/regulatory-expectations-for-remote-audit-planning-and-execution-2/2026-05-02T02:48:00+00:00https://www.gmpguideline.com/inadequate-control-of-shared-records-and-secure-file-transfer-during-audits/2026-05-02T05:22:00+00:00https://www.gmpguideline.com/failure-to-verify-documentary-evidence-during-remote-audits-2/2026-05-02T04:05:00+00:00https://www.gmpguideline.com/inadequate-control-of-shared-records-and-secure-file-transfer-during-audits-2/2026-05-02T05:22:00+00:00https://www.gmpguideline.com/remote-audit-scope-limitations-affecting-compliance-conclusions/2026-05-02T06:39:00+00:00https://www.gmpguideline.com/insufficient-visual-verification-of-facilities-during-virtual-audits/2026-05-02T07:56:00+00:00https://www.gmpguideline.com/remote-audit-scope-limitations-affecting-compliance-conclusions-2/2026-05-02T06:39:00+00:00https://www.gmpguideline.com/insufficient-visual-verification-of-facilities-during-virtual-audits-2/2026-05-02T07:56:00+00:00https://www.gmpguideline.com/documentation-gaps-in-remote-audit-evidence-and-reports/2026-05-02T09:13:00+00:00https://www.gmpguideline.com/regulatory-risks-from-overreliance-on-remote-audit-methods/2026-05-02T10:30:00+00:00https://www.gmpguideline.com/audit-trail-concerns-when-evidence-is-shared-electronically/2026-05-02T11:47:00+00:00https://www.gmpguideline.com/remote-audit-follow-up-weaknesses-for-critical-observations/2026-05-02T13:04:00+00:00https://www.gmpguideline.com/training-deficiencies-affecting-virtual-auditor-effectiveness/2026-05-02T14:21:00+00:00https://www.gmpguideline.com/supplier-oversight-risks-associated-with-incomplete-remote-audits/2026-05-02T15:38:00+00:00https://www.gmpguideline.com/technology-failures-impacting-integrity-of-remote-audit-activities/2026-05-02T16:55:00+00:00https://www.gmpguideline.com/misinterpretation-of-glp-requirements-in-gmp-labs/2026-05-04T18:58:00+00:00https://www.gmpguideline.com/regulatory-risks-from-inconsistent-criticality-classification/2026-05-04T18:58:00+00:00https://www.gmpguideline.com/poor-risk-justification-for-choosing-virtual-instead-of-onsite-audits/2026-05-02T18:12:00+00:00https://www.gmpguideline.com/escalation-gaps-for-unresolved-issues-identified-during-remote-audits/2026-05-02T19:29:00+00:00https://www.gmpguideline.com/effectiveness-review-deficiencies-in-remote-audit-programs/2026-05-02T20:46:00+00:00